Ann: Encouraging Initial Data from CYP-006TK DFU Trial, page-26

he likes to buy high and sell low. Once price goes up he believes planting seeds of doubt trying to shake weak hands is a sound move. Unfortunately people arent that stupid.

anyone with any form of medical backround or even a surface level of knowledge regarding wound care can see a n absolute necessity for this product.

not all wounds many get worse. A wound to heal by any margin in the elderly is amazing.

once you hear an elderly women sob while her wound is being debrided the smell alone makes your stomach turn. You are after all watching a human slowly decompose

this is a massive leap forward for patient care. And why I have been topping up regularly. Now up over 60% true value is many mulitples higher. This is a global problem. A product that improves quality of life, diabetic foot ulcers will not be the only application for this product.

the market loves sexy companies with easy to understand markets. Cyp is not a sexy company but they are producing a product that if successful will become a staple in clinics world wide. This will become a TO target very quickly.